Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Researchers corroborate the importance of exercise for cognitive function

Researchers corroborate the importance of exercise for cognitive function

Memory: a revolutionary treatment for mental health disorders and neurodegeneration?

Memory: a revolutionary treatment for mental health disorders and neurodegeneration?

Hurricane Ian’s deadly impact on Florida seniors exposes need for new preparation strategies

Hurricane Ian’s deadly impact on Florida seniors exposes need for new preparation strategies

Researchers unravel how the brain chemical dopamine relates to schizophrenia

Researchers unravel how the brain chemical dopamine relates to schizophrenia

Scientists reveal anti-inflammatory molecules that play an important role in aging

Scientists reveal anti-inflammatory molecules that play an important role in aging

Appel Alzheimer's Disease Research Institute Symposium reveals new developments in dementia research

Appel Alzheimer's Disease Research Institute Symposium reveals new developments in dementia research

Huntington's disease impairs autophagy in older patients

Huntington's disease impairs autophagy in older patients

Proof-of-principle study: Novel tool advances potential way to deliver gene therapy

Proof-of-principle study: Novel tool advances potential way to deliver gene therapy

New discovery may change the textbook model of GPCR-mediated signaling

New discovery may change the textbook model of GPCR-mediated signaling

Higher exposure to particulate matter may be associated with increased dementia risk

Higher exposure to particulate matter may be associated with increased dementia risk

Subarachnoid hemorrhage incidence is higher and increasing in Black patients, study says

Subarachnoid hemorrhage incidence is higher and increasing in Black patients, study says

$10.3 million NIH grant to support URI neuroscientist's research on retinal scanning to detect early-stage Alzheimer’s

$10.3 million NIH grant to support URI neuroscientist's research on retinal scanning to detect early-stage Alzheimer’s

Exploring new therapeutic targets and biomarkers for neurodegenerative disorders

Exploring new therapeutic targets and biomarkers for neurodegenerative disorders

Discovery could affect the search for new Alzheimer's drugs

Discovery could affect the search for new Alzheimer's drugs

Study estimates the burden of dementia among older adults in the U.S.

Study estimates the burden of dementia among older adults in the U.S.

Novel oxytocin derivative can reverse Aβ25-35-induced cognitive impairment in mice

Novel oxytocin derivative can reverse Aβ25-35-induced cognitive impairment in mice

Family caregivers find support on #dementia TikTok

Family caregivers find support on #dementia TikTok

Weight change in the early stages of Parkinson's disease may be linked with changes in thinking skills

Weight change in the early stages of Parkinson's disease may be linked with changes in thinking skills

Salk's three collaborative projects win 2022 Curebound Discovery Grant

Salk's three collaborative projects win 2022 Curebound Discovery Grant

Researchers develop a powerful computational tool for understanding brain health and disease

Researchers develop a powerful computational tool for understanding brain health and disease